Clinical trials
Expanded access Leukemia, Myeloid, Acute trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| No longer available | 6 |
| Approved for marketing | 3 |
| Available | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 2 |
| Astellas Pharma Global Development, Inc. | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Christopher Dvorak | 1 |
| Emory University | 1 |
| Genelux Corporation | 1 |
| Joanne Kurtzberg, MD | 1 |
| Novartis Pharmaceuticals | 1 |
| Orca Biosystems, Inc. | 1 |
| Wake Forest University Health Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 11 |
| Myelodysplastic Syndromes | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Lymphoma | 3 |
| Congenital Abnormalities | 2 |
| Graft vs Host Disease | 2 |
| Hematologic Neoplasms | 2 |
| Immunologic Deficiency Syndromes | 2 |
| Leukemia | 2 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.